ORM Evidence

Filings / Leidos

LEIDOS BIOMEDICAL RESEARCH INC

Federal contract award, Leidos, $53,523,069

Key CONT_AWD_75N91018F00077_7529_HHSN261201500003I_7529. First seen by this system September 5, 2026 through the historical sweep, new to the watchlist, public 379 days before this system saw it. One version on record.

Cite this row

On this site https://evidence.ourrevolution.media/filings/leidos/CONT_AWD_75N91018F00077_7529_HHSN261201500003I_7529
At the source https://www.usaspending.gov/award/CONT_AWD_75N91018F00077_7529_HHSN261201500003I_7529
Observed 2026-09-05, version 1, retrieved 2026-09-05T00:54:32Z
Content hash 97d8bc2747ab8ff36e97227db61c8b8530247d1fbcbb1c66c1d491f9a0ba0276

The source record can change after this date; the key, hash and retrieval time name exactly the response this system stored. See license and citation.

Versions

VersionAmountChangeOccurredPublishedRetrievedHow it arrivedContent hash
1
current
$53,523,069first versionSeptember 20, 2018August 22, 20252026-09-05T00:54:32Zhistorical sweep97d8bc2747ab

Archived copy

https://web.archive.org/web/20261011010448/https://www.usaspending.gov/award/CONT_AWD_75N91018F00077_7529_HHSN261201500003I_7529 captured by this system, October 11, 2026

What the amount is made of

14 recorded actions, so the amount is the award's current total across all of them. 5 of them obligated money. Measured 2026-10-12, when USAspending reported a total obligation of $53,523,069.

Action dateModificationTypeObligatedDescription as recorded
August 22, 2025P00013OTHER ADMINISTRATIVE ACTIONno moneyMOD 13 - SOW REVISION PER NCI COR (RAY HARRIS) REQUEST
April 23, 2025P00012OTHER ADMINISTRATIVE ACTIONno moneyEOI:: IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI
August 30, 2024P00011OTHER ADMINISTRATIVE ACTION+$13,633,885CELL-BASED IMMUNOTHERAPY PRODUCTS MOD 011 - EXERCISE OPTION 02
August 22, 2024P00010FUNDING ONLY ACTION−$541,868CELL-BASED IMMUNOTHERAPY PRODUCTS MOD 010 - PLIN 2 DE-OBLIGATION
March 14, 2024P00009OTHER ADMINISTRATIVE ACTION+$541,724CELL-BASED IMMUNOTHERAPY PRODUCTS MOD 009
September 29, 2023P00008OTHER ADMINISTRATIVE ACTIONno moneyCELL-BASED IMMUNOTHERAPY PRODUCTS
August 25, 2023P00007OTHER ADMINISTRATIVE ACTION+$6,585,449CELL-BASED IMMUNOTHERAPY PRODUCTS
May 2, 2023P00006OTHER ADMINISTRATIVE ACTIONno moneyCELL-BASED IMMUNOTHERAPY PRODUCTS
February 22, 2023P00005OTHER ADMINISTRATIVE ACTIONno moneyCELL-BASED IMMUNOTHERAPY PRODUCTS
June 30, 2022P00004OTHER ADMINISTRATIVE ACTIONno moneyCELL-BASED IMMUNOTHERAPY PRODUCTS
February 10, 2022P00003OTHER ADMINISTRATIVE ACTIONno moneyCELL-BASED IMMUNOTHERAPY PRODUCTS
December 23, 2021P00002OTHER ADMINISTRATIVE ACTIONno moneyCELL-BASED IMMUNOTHERAPY PRODUCTS
May 27, 2021P00001OTHER ADMINISTRATIVE ACTIONno moneyCELL-BASED IMMUNOTHERAPY PRODUCTS
September 20, 2018basenot on file+$33,303,879CELL-BASED IMMUNOTHERAPY PRODUCTS

Last refreshed November 4, 2026 at 2:31 PM UTC.